Calliditas - Year-End Report, 2022 ...Middle East

2022: Successful transformation into a commercial stage company STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- "2022 was a fantastic year for Calliditas as we launched TARPEYO® in the US, the first approved drug for IgA nephropathy and a medication with the potential to be disease modifying...

Hence then, the article about calliditas year end report 2022 was published today ( Thursday 23/02/2023 - 09:48 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Calliditas - Year-End Report, 2022 )

Also on site :

• 1968 ‘Magnetic’ Classic Was a No. 1 Hit 58 Years Ago Today
• Юридическая фирма Kasowitz LLP опубликовала актуализированный отчет, посвященный анализу нарушений фундаментальных процессуальных норм как основания для дальнейшего содержания под стражей и судебного преследования мэра Тираны (Албания) Эрио
• Asia rolls out four-day weeks and work-from-home as emergency measures to solve a fuel crisis caused by Iran war